Phase I study of MGI 114 (irofulven) exploring 3 different iv schedules (SCH) as a 5 minute infusion in advanced solid tumors (AST): final results

Authors :: S. Smith
M. Ould Kaci
K. Vanderbilt
E. Brain
Esteban Cvitkovic
S. Lagree
Eric Raymond
Carmen Kahatt
S. Chieze
Jérôme Alexandre
Source :: European Journal of Cancer. 37:S71
Publication Year :: 2001
Publisher :: Elsevier BV, 2001.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
chemistry.chemical_compound
chemistry
business.industry
Internal medicine
Medicine
Irofulven
business
Intensive care medicine
Phase i study

Full Text Access

Tools